This review aimed to update current knowledge on causality and risk relationships to inform global and national comparative risk assessments for alcohol.
This review aimed to update current knowledge on causality and risk relationships to inform global and national comparative risk assessments for alcohol.
This article highlights state-level progress toward pharmacist reimbursement since the 2024 manuscript on this topic. A special thanks to the many AAPP members who assisted in the research and authorship of this manuscript which highlights expansion of pharmacist test-and-treat authority, new commercial coverage mandates, explicit Medicaid provider enrollment and reimbursement structures, and broadened scope-of-practice provisions tied to payment.
This systematic review and meta-analysis indicated a small association between antidepressants and ADHD or ASD.
No summary available
This talk will provide a background on traditional kratom and an overview of the recent proliferation of novel, kratom-derived products. Industry marketing, confused media coverage, and dynamic government policy will be described, as all influence public health responses.
This study provides key insights into the resource/cost requirements for implementing and sustaining each A.S.K.-PrEP strategy.
Police stop-and-search was associated with elevated subsequent overdose risk among PWUD.
In this trial of healthy adults who co-used cannabis and alcohol, cannabis edibles combined with alcohol augmented driving impairment.
This review identified that ketamine treatment was associated with instances of elevated liver enzymes.
These data indicate a need to identify and disseminate successful hospital-based strategies to increase prescribing of MAUD.
This study calculated frequencies and measures of central tendency.
These results suggest that MOUD access in supportive housing should be expanding, which could require embedding addiction care into PSH teams, leveraging behavioral health touchpoints, and addressing persistent disparities.
This episode examines how pharmacy-based models are closing gaps in addiction care deserts, how pharmacists can strengthen interdisciplinary care teams, and why fair reimbursement for pharmacist services matters for sustaining care in the communities hit hardest by overdose.
This paper introduces behavioral health, Medicaid, and public health agency leaders, administrators, managers, and policymakers to selected public child- and family-serving systems.
AAPP's newest policy brief addresses misinformation about the association between antidepressants and violence, emphasizing the safety and benefits of antidepressants for treating various mental health disorders.
Clinicians are rightly expected to disclose their gaps in knowledge or their inability to forecast an outcome. Yet emerging AI tools often cannot, or will not, do the same.
Findings from this study suggest that restrictive policies on antidepressant prescribing are unlikely to align with public sentiment and may risk exacerbating existing inequities in care.
This SAMHSA advisory outlines evidence-based strategies to integrate physical and behavioral health services, improving outcomes, reducing costs, and enhancing quality of life.
Findings of this meta-analysis suggest that ketamine may be considered an off-label treatment for those at risk of suicidal behaviors or those not responding to other treatments for depression.
AAPP member Farah Khorassani explains her vital role on the care team.
LGBTQ+ young people who reported living in very accepting communities attempted suicide at less than a third of the rate of those who did not.
The incidence and risk elevation of incident mental disorders in cancer patients vary based on sex, cancer type, time since diagnosis and type of mental disorder.
Referring patients to behavioral health specialists for CBT and/or prescribing recommended pharmacotherapy with Collaborative Care Management can help to reduce patient morbidity and improve functioning.
These data indicate a need to identify and disseminate successful hospital-based strategies to increase prescribing of MAUD.
The link between specialty-care-only policies and lower diversion and overdose risk is not supported by the reviewed literature.